Results: 4

1.
<b>Figure 3.</b>

Figure 3.. From: Impact of the Lung Allocation Score on Lung Transplantation for Pulmonary Arterial Hypertension.

Cumulative incidence curves comparing post-transplant mortality before and after implementation of the Lung Allocation Score (LAS) for idiopathic pulmonary arterial hypertension, idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease, and cystic fibrosis combined. Dashed line = pre-LAS; solid line = post-LAS.

Hubert Chen, et al. Am J Respir Crit Care Med. 2009 September 1;180(5):468-474.
2.
<b>Figure 4.</b>

Figure 4.. From: Impact of the Lung Allocation Score on Lung Transplantation for Pulmonary Arterial Hypertension.

Cumulative incidence curves comparing post-transplant mortality between diagnoses before and after implementation of the Lung Allocation Score (LAS). Idiopathic pulmonary arterial hypertension (solid line). Idiopathic pulmonary fibrosis (dashed line). Chronic obstructive pulmonary disease (gray line). Cystic fibrosis (dotted line).

Hubert Chen, et al. Am J Respir Crit Care Med. 2009 September 1;180(5):468-474.
3.
<b>Figure 1.</b>

Figure 1.. From: Impact of the Lung Allocation Score on Lung Transplantation for Pulmonary Arterial Hypertension.

Cumulative incidence curves comparing transplantation and death on the waiting list before and after implementation of the Lung Allocation Score (LAS) for idiopathic pulmonary arterial hypertension, idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease, and cystic fibrosis combined. Dashed line = pre-LAS; solid line = post-LAS.

Hubert Chen, et al. Am J Respir Crit Care Med. 2009 September 1;180(5):468-474.
4.
<b>Figure 2.</b>

Figure 2.. From: Impact of the Lung Allocation Score on Lung Transplantation for Pulmonary Arterial Hypertension.

Cumulative incidence curves comparing transplantation and death on the waiting list between diagnoses before and after implementation of the Lung Allocation Score (LAS). Idiopathic pulmonary arterial hypertension (solid line). Idiopathic pulmonary fibrosis (dashed line). Chronic obstructive pulmonary disease (gray line). Cystic fibrosis (dotted line).

Hubert Chen, et al. Am J Respir Crit Care Med. 2009 September 1;180(5):468-474.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk